CAS: 4214-13-5; 3-Methoxy-Dl-Tyrosine

结构式图片

MSDS等安全信息

    上下游产品

    levodopa (S)-2-Amino-3-(4-hydroxy-3-methoxy-phenyl)-propionic acid methyl ester L-3-(3-methoxy-4-(benzyloxy)phenyl)-N-(benzyloxycarbonyl)alanine methyl ester L-3-(3-acetyl-4-hydroxyphenyl)-N-(benzyloxycarbonyl)alanine methyl ester 3-methoxy-4-hydroxy-L-phenylalanine methyl ester hydr°Chloride L-dopaquinone 3,4-dihydroxy-6-fluoro-L-phenylalanine

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-12421534-B2
      优先权日:2021-11-10
      标 题 :Engineered enzymes and method for the synthesis of diverse tyrosine analogs
      发明人:ALMHJELL PATRICK J; ARNOLD FRANCES H
      权利人:CALIFORNIA INST OF TECHN
      摘要:Provided herein is an engineered tryptophan synthase β-subunit (TrpB) that catalyzes the synthesis of tyrosine, tyrosine analogs, or salts thereof. Also provided herein are methods for preparing tyrosine, tyrosine analogs, or a salt thereof using the engineered TrpB described herein.

      专利号:US-5801047-A
      优先权日:1992-11-25
      标题:Method for making stable extracellular tyrosinase and synthesis of polyphenolic polymers therefrom
      发明人:DELLA-CIOPPA GUY RICHARD; GARGER JR STEPHEN JOHN; HOLTZ RICHARD BARRY; MCCULLOCH MICHAEL JAY; SVERLOW GENADIE GLEB
      权利人:BIOSOURCE TECH INC
      摘要:A process for the in vitro production of chemically modified polyphenolic polymer (PPP). First, stable, highly active extracellular tyrosinase is produced from genetically transformed microorganism such as Streptomyces antibioticus. The tyrosinase is then incubated with a reaction substrate such as 1-tyrosine, hydrolyzed protein, or an oligopeptide in combination with 1-tyrosine. The ratio of the oligopeptide/tyrosine combination as well as variation in the concentration of tyrosinase can be used to modify the color, the molecular size, and the spectral absorbance properties of the PPP produced. Alternatively, or additionally, oxidants such as hydrogen peroxide or hypochlorite can be used to modify the color of the PPP, regardless of the method used to produce the PPP, and the PPP can subsequently be fractionated using molecular weight cut-off ultrafiltration. Organic solvents can also be used in the method of making PPP to produce PPPs having variable but reproducible physical properties.

      专利号:US-2023037284-A9
      优先权日:2018-11-30
      标题:Combination therapy of peptidomimetic macrocycles
      发明人:GUERLAVAIS VINCENT; ANNIS DAVID ALLEN
      权利人:AILERON THERAPEUTICS INC
      摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

      专利号:US-2004110228-A1
      优先权日:2002-04-01
      标 题:Combinatorial organic synthesis of unique biologically active compounds
      发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
      摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

      专利号:US-2025084410-A1
      优先权日:2015-01-12
      标 题:Incorporation of unnatural nucleotides and methods thereof
      发明人:PTACIN JEROD; MALYSHEV DENIS A; CAFFARO CAROLINA E
      权利人:SYNTHORX INC
      摘要:Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.

      专利号:US-2018371021-A1
      优先权日:2017-05-11
      标 题 :Peptidomimetic macrocycles and uses thereof
      发明人:AIVADO MANUEL; GUERLAVAIS VINCENT; OLSON KAREN
      权利人:AILERON THERAPEUTICS INC
      摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      参考文献:10.1023/a:1005539803576
      摘要:Wevers RA, de Rijk-van Andel JF, Bräutigam C, Geurtz B, van den Heuvel LP, Steenbergen-Spanjers GC, Smeitink JA, Hoffmann GF, Gabreëls FJ. A review of biochemical and molecular genetic aspects of tyrosine hydroxylase deficiency including a novel mutation (291delC). J Inherit Metab Dis. 1999 Jun;22(4):364–73. doi: 10.1023/a:1005539803576.
      参考文献:10.1007/bf01291793
      摘要:Naumann M, Götz M, Reiners K, Lange KW, Riederer P. Neurotransmitters in CSF of idiopathic adult-onset dystonia: reduced 5-HIAA levels as evidence of impaired serotonergic metabolism. J Neural Transm (Vienna). 1996;103(8-9):1083–91. doi: 10.1007/bf01291793.
      参考文献:10.1007/bf01271189
      摘要:Brannan T, Prikhojan A, Yahr MD. An in vivo comparison of the capacity of striatal versus extrastriatal brain regions to form dopamine from exogenously administered L-dopa. J Neural Transm (Vienna). 1996;103(11):1287–94. doi: 10.1007/bf01271189.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知